Furthermore, a growing body of evidence suggests that G protein mechanisms, such as GIRK channels [33–35] and Gɑi signaling [36], are responsible for opioid-induced respiratory depression, and low G protein efficacy explains the reduced respiratory effect observed with the newer ultra-biased ligands [20]. The gene discussed is GNAI1; the disease is respiratory depression.